Organoruthenium metallocycle induced mutation in gld-1 tumor suppression gene in JK1466 strain and appreciable lifespan expansion.

Four Ru(II) complexes (A2-A5) were synthesized from the reaction of coumarin Schiff base ligands (7da2-tsc, 7da3-mtsc, 7da4-etsc and 7da5-ptsc) with [RuHCl(CO)(PPh3)3]. The compounds were characterized by FT-IR, UV-Vis, 1H, 13C and 31P NMR, mass spectrometry and crystallographic analysis. Calf Thymus DNA (CT-DNA) binding studies revealed the intercalative mode of binding of the complexes with DNA. The results of Bovine serum albumin (BSA) binding studies established the interaction between BSA followed static quenching mechanism. The cytotoxic effects of the complexes and the ligands were evaluated against breast (MCF-7 and MDA-MB-231) and lung carcinoma cell lines (A549 and NCI-H460) using MTT assay. Complex A4 demonstrated potent cytotoxic effects on both breast and lung cancer cells. Furthermore, morphological observations and FACS analysis showed the decrease in cell density by complex A4 by induced morphological changes and apoptotic body formation and cell death in both breast and lung cancer cells. Moreover, the invertebrate model Caenorhabditis elegans was employed to assess the in vivo anticancer activity of compound A4. The findings indicated that the treatment with A4 reduced tumor development and significantly extended organismal lifespan by 64 % in the tumoral strain JK1466 without adversely affecting essential physiological functions of the worm. Additionally, A4 demonstrated an upregulation of two crucial antioxidant defense genes. Overall, these results suggested that the compound A4 can be a potential candidate with novel chemotherapeutic applications.

An investigation on 3-acetyl-7-methoxy-coumarin Schiff bases and their Ru(ii) metallates with potent antiproliferative activity and enhanced LDH and NO release.

New cyclometallated ruthenium(ii) complexes of 3-acetyl-7-methoxycoumarin-4N-substituted thiosemicarbazones were synthesized and characterized by analytical and spectral techniques. The crystal structures of the ligands H2L1-3 and complexes (1, 2 and 4) were confirmed by X-ray crystallography. The analysis showed that the ligands have undergone C-H activation at the C(4) carbon of the pyrone ring and acted in a tridentate fashion by binding through C, N and S atoms. CT-DNA and protein (BSA/HSA) binding studies were carried out to analyze their interaction with biomolecules. Good binding affinity with DNA was observed with intercalative binding mode, which was further confirmed by EB displacement and viscosity measurement studies. The quenching mechanism with BSA/HSA was found to be static. Three dimensional (3D) fluorescence measurements were carried out to validate the micro environmental changes in the serum albumins. Their antioxidant propensity and antimicrobial study insisted that the compounds displayed good spectrum of activity. Evaluation of their anticancer potential against MCF-7 (human breast cancer) and A549 (human lung carcinoma) cell lines revealed that the complexes exhibited better activity than the ligands and cisplatin. Further, the results of LDH and NO release assays supported the cytotoxic nature of the compounds. The non-toxic nature of the compounds was established by testing against the non-cancerous cell line HaCaT (human normal keratinocyte).

New p-tolylimido rhenium(V) complexes with carboxylate-based ligands: synthesis, structures and their catalytic potential in oxidations with peroxides.

Novel p-tolylimido rhenium(v) complexes trans-(Cl,Cl)-[Re(p-NC6H4CH3)Cl2(pyz-2-COO)(PPh3)]·MeCN (1), trans-(Cl,Cl)-[Re(p-NC6H4CH3)Cl2(pyz-2-COO)(PPh3)] (2), trans-(Br,Br)-[Re(p-NC6H4CH3)Br2(pyz-2-COO)(PPh3)] (3), cis-(Cl,Cl)-[Re(p-NC6H4CH3)Cl2(ind-3-COO)(PPh3)]·2MeOH (4), 2[Re(p-NC6H4CH3)Cl2(ind-3-COO)(PPh3)]·MeCN (5), 2[Re(p-NC6H4CH3)Br2(ind-3-COO)(PPh3)]·MeOH (6) and 2[Re(p-NC6H4CH3)Br2(ind-3-COO)(PPh3)]·MeCN (7) were obtained in the reactions of [Re(p-NC6H4CH3)X3(PPh3)2] (X = Cl, Br) with pyrazine-2-carboxylic (pyz-2-COOH or PCA) and indazole-3-carboxylic (ind-3-COOH) acids. The compounds were identified by elemental analysis, IR, (1)H, (13)C and (31)P NMR spectroscopy and X-ray crystallography. To get a deeper understanding of the structural and bonding properties of the imido rhenium(v) complexes, calculations at the DFT level were undertaken for trans-(Cl,Cl)-[Re(p-NC6H4CH3)Cl2(pyz-2-COO)(PPh3)] and cis-(Cl,Cl)-[Re(p-NC6H4CH3)Cl2(ind-3-COO)(PPh3)]. Complexes 1, 3, 4 and 6 exhibited high catalytic activity in oxidation of alkanes with H2O2 and tert-butyl hydroperoxide (TBHP) and of alcohols with TBHP. The selectivity parameters measured in the reactions with linear and branched alkanes indicated that the processes with H2O2 or TBHP proceed with the participation of hydroxyl or tert-butoxyl radicals, respectively. The composition of isomers from oxygenation of methylcyclohexane corresponds to the existence of some steric hindrance around the reaction centers.

Copper-D-penicillamine complex as potential contrast agent for MRI.

In vitro and in vivo proton T1 data are reported that demonstrate that the paramagnetic copper-D-penicillamine complex can be applied as a potential contrast agent to magnetic resonance imaging.